摘要WHO于2016年提出了2030年消除乙型肝炎(乙肝)作为公共卫生威胁的目标.我国是世界上HBV感染负担最重的国家,是全球实现2030年消除乙肝目标的主要贡献者.在过去30年中我国在预防控制HBV感染方面取得了巨大的进展,具有了实现WHO 2030目标的基础.然而,由于我国人口基数大,现存感染者人数多,诊断与治疗的覆盖率不高,要按时达到WHO2030目标仍面临较大挑战.本文从乙肝疫苗接种、HBV母婴阻断、血液安全和注射安全保障、HBV感染的诊断与治疗等方面分别阐述了我国预防控制HBV感染的成就与差距,分析了我国达到WHO 2030消除乙肝目标面临的挑战与实现的基础,提出了我国达到WHO 2030消除乙肝目标的相关政策建议.

abstractsIn 2016,the WHO proposed the goal for elimination of hepatitis B as public health threat,by 2030.China has the heaviest burden caused by hepatitis B virus (HBV) infection in the world,and serves as the major contributor to the goal of eliminating hepatitis B by 2030,globally.During the past 30 years,great progress has been made towards the implementation on prevention and control programs of HBV infection,in China,that enabling the WHO 2030 target to be fulfilled.However,due to the size of population,the large number of HBV infections and the low coverage of diagnosis and treatment programs,China is still facing the challenge in reaching the 2030 target,on time.This paper elaborates the achievements and gaps regarding the on-going prevention and control programs,including vaccination,prevention of maternal-to-child transmission,blood and injection safety,diagnosis and treatment on HBV infection and putting forward several suggestions on relevant policies for achieving the goal of hepatitis B elimination by 2030,in China.